Dr Kent Brantly, 33, thanked supporters for their prayers at
a news conference in Atlanta. Nancy Writebol, 59, was discharged on Tuesday.
The two were brought to the US for treatment three weeks
ago.
The outbreak has killed more than 1,300 people in West
Africa, with many of the deaths occurring in Liberia.
“Today is a miraculous day,” said Dr Brantly, who appeared
healthy if pallid as he addressed reporters yesterday at Emory University
hospital.
“I am thrilled to be alive, to be well, and to be reunited
with my family. As a medical missionary, I never imagined myself in this
position.”
After his family returned to the US as the Ebola outbreak
tore through West Africa, he continued to treat Ebola patients and woke up on
July 23 feeling “under the weather”.
Dr Brantly said he lay in bed for nine days, getting
progressively sicker and weaker. On 1 August, he was flown to Atlanta for
treatment at Emory.
Emory infectious disease specialist Dr Bruce Ribner said
after rigorous treatment and testing, officials were confident Dr Brantly had
recovered “and he can return to his family, his community and his life without
public health concerns”.
The group for which he was working in Liberia, Samaritan’s
Purse, said they were celebrating his recovery.
“Today I join all of our Samaritan’s Purse team around the
world in giving thanks to God as we celebrate Dr Kent Brantly’s recovery from
Ebola and release from the hospital,” Franklin Graham said in a statement.
Nancy Writebol’s husband David said in a statement that she
was free of the virus but was significantly weakened.
The family decided to leave the hospital privately in order
to allow her to rest and recuperate.
Both Dr Brantly and Mrs Writebol received an experimental
treatment known as ZMapp.
The drug, which has only been made in extremely limited
qualities, had never been tested on humans and it remains unclear if it is
responsible for their recovery.
ZMapp was also given to a Spanish priest, who died, and
three Liberian health workers, who are showing signs of improvement.
No comments:
Post a Comment